These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 28107393)
1. T Cell Subset and Stimulation Strength-Dependent Modulation of T Cell Activation by Kv1.3 Blockers. Fung-Leung WP; Edwards W; Liu Y; Ngo K; Angsana J; Castro G; Wu N; Liu X; Swanson RV; Wickenden AD PLoS One; 2017; 12(1):e0170102. PubMed ID: 28107393 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes. Hu L; Pennington M; Jiang Q; Whartenby KA; Calabresi PA J Immunol; 2007 Oct; 179(7):4563-70. PubMed ID: 17878353 [TBL] [Abstract][Full Text] [Related]
3. Lovastatin blocks Kv1.3 channel in human T cells: a new mechanism to explain its immunomodulatory properties. Zhao N; Dong Q; Qian C; Li S; Wu QF; Ding D; Li J; Wang BB; Guo KF; Xie JJ; Cheng X; Liao YH; Du YM Sci Rep; 2015 Nov; 5():17381. PubMed ID: 26616555 [TBL] [Abstract][Full Text] [Related]
4. The effects of Kv1.3 and IKCa1 potassium channel inhibition on calcium influx of human peripheral T lymphocytes in rheumatoid arthritis. Toldi G; Bajnok A; Dobi D; Kaposi A; Kovács L; Vásárhelyi B; Balog A Immunobiology; 2013 Mar; 218(3):311-6. PubMed ID: 22705192 [TBL] [Abstract][Full Text] [Related]
5. [Kv1.3 potassium channel expression changes after CD4(+) and subsets CD28(null)/CD28(+)T cells activation in peripheral blood of patients with acute coronary syndrome]. Feng DY; Zhang CT; Ma YX; Zhou HL; Xu RD; Yang XW; Huang S; Ma J; Quan XQ Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jul; 37(7):599-604. PubMed ID: 19961728 [TBL] [Abstract][Full Text] [Related]
6. Kv1.3 blockers ameliorate allergic contact dermatitis by preferentially suppressing effector memory T cells in a rat model. Ueyama A; Imura K; Kasai-Yamamoto E; Tai N; Nagira M; Shichijo M; Yasui K Clin Exp Dermatol; 2013 Dec; 38(8):897-903. PubMed ID: 24252082 [TBL] [Abstract][Full Text] [Related]
7. The anti-proliferative effect of cation channel blockers in T lymphocytes depends on the strength of mitogenic stimulation. Petho Z; Balajthy A; Bartok A; Bene K; Somodi S; Szilagyi O; Rajnavolgyi E; Panyi G; Varga Z Immunol Lett; 2016 Mar; 171():60-9. PubMed ID: 26861999 [TBL] [Abstract][Full Text] [Related]
8. Blockade of Kv1.3 potassium channels inhibits differentiation and granzyme B secretion of human CD8+ T effector memory lymphocytes. Hu L; Wang T; Gocke AR; Nath A; Zhang H; Margolick JB; Whartenby KA; Calabresi PA PLoS One; 2013; 8(1):e54267. PubMed ID: 23382885 [TBL] [Abstract][Full Text] [Related]
10. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Matheu MP; Beeton C; Garcia A; Chi V; Rangaraju S; Safrina O; Monaghan K; Uemura MI; Li D; Pal S; de la Maza LM; Monuki E; Flügel A; Pennington MW; Parker I; Chandy KG; Cahalan MD Immunity; 2008 Oct; 29(4):602-14. PubMed ID: 18835197 [TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells. Pucca MB; Bertolini TB; Cerni FA; Bordon KC; Peigneur S; Tytgat J; Bonato VL; Arantes EC Immunology; 2016 Feb; 147(2):240-50. PubMed ID: 26595158 [TBL] [Abstract][Full Text] [Related]
12. Lymphocyte calcium influx characteristics and their modulation by Kv1.3 and IKCa1 channel inhibitors in healthy pregnancy and preeclampsia. Toldi G; Stenczer B; Treszl A; Kollár S; Molvarec A; Tulassay T; Rigó J; Vásárhelyi B Am J Reprod Immunol; 2011 Feb; 65(2):154-63. PubMed ID: 20649894 [TBL] [Abstract][Full Text] [Related]
13. Acacetin blocks kv1.3 channels and inhibits human T cell activation. Zhao N; Dong Q; Fu XX; Du LL; Cheng X; Du YM; Liao YH Cell Physiol Biochem; 2014; 34(4):1359-72. PubMed ID: 25301362 [TBL] [Abstract][Full Text] [Related]
14. 18β-Glycyrrhetinic acid potently inhibits Kv1.3 potassium channels and T cell activation in human Jurkat T cells. Fu XX; Du LL; Zhao N; Dong Q; Liao YH; Du YM J Ethnopharmacol; 2013 Jul; 148(2):647-54. PubMed ID: 23707333 [TBL] [Abstract][Full Text] [Related]
15. N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3. Chang SC; Huq R; Chhabra S; Beeton C; Pennington MW; Smith BJ; Norton RS FEBS J; 2015 Jun; 282(12):2247-59. PubMed ID: 25864722 [TBL] [Abstract][Full Text] [Related]
16. Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog. Tanner MR; Tajhya RB; Huq R; Gehrmann EJ; Rodarte KE; Atik MA; Norton RS; Pennington MW; Beeton C Clin Immunol; 2017 Jul; 180():45-57. PubMed ID: 28389388 [TBL] [Abstract][Full Text] [Related]
17. Different calcium influx characteristics upon Kv1.3 and IKCa1 potassium channel inhibition in T helper subsets. Orbán C; Bajnok A; Vásárhelyi B; Tulassay T; Toldi G Cytometry A; 2014 Jul; 85(7):636-41. PubMed ID: 24827427 [TBL] [Abstract][Full Text] [Related]